Start Date

29-4-2021 7:15 PM

End Date

29-4-2021 7:25 PM

Document Type

Poster

Description

Psoriasis is one of the most common skin conditions in the United States affecting more than 8 million people. High amounts of vitamin D has been shown to be effective in treatment of psoriasis. It also has a well-documented safety profile at the doses and duration that will be used during this study. Triamcinolone and other topical corticosteroids are considered a first line treatment for mild to moderate psoriasis with a well-documented safety profile. Individually both of these medications have shown effectiveness in the management and treatment of mild to moderate psoriasis. This study is designed to test whether a combination therapy of topical 0.1% triamcinolone with 40,000 IU vitamin D3 daily is effective in treating mild to moderate psoriasis.

Additional Files

Repas_2021 BSOM Medical Student Symposium Abstract-ocr.pdf (123 kB)
Abstract - Repas


Share

COinS
 
Apr 29th, 7:15 PM Apr 29th, 7:25 PM

Triamcinolone with Vitamin D Synergistic Efficacy in Psoriasis

Psoriasis is one of the most common skin conditions in the United States affecting more than 8 million people. High amounts of vitamin D has been shown to be effective in treatment of psoriasis. It also has a well-documented safety profile at the doses and duration that will be used during this study. Triamcinolone and other topical corticosteroids are considered a first line treatment for mild to moderate psoriasis with a well-documented safety profile. Individually both of these medications have shown effectiveness in the management and treatment of mild to moderate psoriasis. This study is designed to test whether a combination therapy of topical 0.1% triamcinolone with 40,000 IU vitamin D3 daily is effective in treating mild to moderate psoriasis.